Predictive value of specimen histology after preoperative radiotherapy in the treatment of bulky/barrel carcinoma of the cervix

Y. Maruyama, J. R. Van Nagell, D. Powell, J. Yoneda, E. Donaldson, H. H. Gallion, R. J. Kryscio

Research output: Contribution to journalArticle

5 Scopus citations

Abstract

One hundred thirty-four patients with bulky and barrel-shaped cervix cancers were treated with preoperative radiation to 40-45 Gy, intracavitary therapy using Cs-137 or Cf-252 and extrafascial total abdominal hysterectomy and bilateral salpingo-oophorectomy (TAHBSO) 4-6 weeks after radiotherapy. Outcome of therapy was traced for patients with residual tumor (positive) in the hysterectomy specimen and those who had no residual tumor (negative) in the specimens. All specimens were studied by a set protocol to carefully evaluate the TAHBSO specimen for gross or residual tumor. Ninety-two percent of the patients with negative specimens survived 5 years, but this dropped to 71% if the specimen was positive. These findings were observed in both the Cs-137- and Cf-252-treated patients. Patients with negative specimens failed mainly in distant sites, whereas those with positive specimens failed locally and distantly. Patient survival was less in patients with positive specimens. There was no difference in outcomes for adenocarcinoma and squamous cell carcinomas. The specimen histological findings have predictive value in patients treated with preoperative radiation and surgery.

Original languageEnglish (US)
Pages (from-to)150-156
Number of pages7
JournalAmerican Journal of Clinical Oncology: Cancer Clinical Trials
Volume15
Issue number2
DOIs
StatePublished - Jan 1 1992

Fingerprint Dive into the research topics of 'Predictive value of specimen histology after preoperative radiotherapy in the treatment of bulky/barrel carcinoma of the cervix'. Together they form a unique fingerprint.

  • Cite this